Maverick Therapeutics IPO

Maverick Therapeutics is a biotech company developing a T cell therapeutic platform designed to eliminate solid tumors. With the platform, T cell activation and resulting cell killing only take place where it is needed, therefore delivering the long sought trifecta in cancer care; high specificity, high potency and reduced toxicity.

Register for Details

For more details on financing and valuation for Maverick Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about Maverick Therapeutics

Forge green plus iconForge green minus icon

When was Maverick Therapeutics founded?

Maverick Therapeutics was founded in 2016.
Updated on: Jun 12, 2022